Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...

Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

Medicaid faces changes, as Trump previously proposed adding work requirements, though he has not addressed this in his ...

A previous version of this article incorrectly said that U.S. restaurant spending is expected to reach $1.22 billion in 2024, ...

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.